Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Markus, Pirlich"'
Autor:
Gunnar Wichmann, Theresa Wald, Markus Pirlich, Joanna Napp, Ina Münter, Thomas Asendorf, Ralf Tostmann, Jeannette Vogt, Kathrin Vogel, Sylvia Meuret, Matthaeus Stoehr, Veit Zebralla, Nils Henrik Nicolay, Thomas Kuhnt, Peter Hambsch, Orlando Guntinas-Lichius, Jens Peter Klußmann, Susanne Wiegand, Andreas Dietz
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The European Larynx Organ Preservation Study (ELOS; NCT06137378) is a prospective, randomized, open-label, two-armed parallel group controlled, phase II multicenter larynx organ preservation (LOP) trial in locoregionally advanced (LA) stage III, IVA/
Externí odkaz:
https://doaj.org/article/5f94c8f6000b4d62860755bd2169dd0e
Autor:
Gunnar Wichmann, Theresa Wald, Markus Pirlich, Matthaeus Stoehr, Veit Zebralla, Thomas Kuhnt, Nils Henrik Nicolay, Peter Hambsch, Irene Krücken, Karl-Titus Hoffmann, Florian Lordick, Regine Kluge, Susanne Wiegand, Andreas Dietz
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionLarynx organ preservation (LOP) in locoregional-advanced laryngeal and hypopharyngeal squamous cell carcinoma (LA-LHSCC) being only R0-resectable (clear margins > 5 mm) by total laryngectomy (TL) is desirable. Based on tumor-specific surv
Externí odkaz:
https://doaj.org/article/2f6ac6d85c7942b39ef649f666a09f20
Autor:
Theresa Wald, Tim-Jonathan Koppe, Markus Pirlich, Veit Zebralla, Viktor Kunz, Andreas Dietz, Matthaeus Stoehr, Gunnar Wichmann
Publikováno v:
Biomedicines, Vol 12, Iss 9, p 2136 (2024)
Background/Objectives: Laryngeal squamous cell carcinoma (LSCC) is among most frequent malignancies of the head and neck. Recent oncologic research focusses on advanced rather than on early stages. Thus, we aimed to improve the knowledge concerning p
Externí odkaz:
https://doaj.org/article/39a63a03a8ec486093ad48eae6b5f75e
Autor:
Louisa Röhl, Jana Wellhausen, Michael Berszin, Irene Krücken, Veit Zebralla, Markus Pirlich, Susanne Wiegand, Andreas Dietz, Theresa Wald, Gunnar Wichmann
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundImmune-checkpoint blockade (ICB) of programmed-death-1 (PD-1) with pembrolizumab or nivolumab is approved for treating recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). NadiHN and ADRISK are phase IIB trials investig
Externí odkaz:
https://doaj.org/article/2844b68fdef74e30ab5deaea9b3f11fe
Publikováno v:
BMC Musculoskeletal Disorders, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Spinal injection has been an accepted part of conservative therapy for degenerative diseases. The drugs used can cause side effects and severe complications. The aim of this study was to determine the occurrence of general side ef
Externí odkaz:
https://doaj.org/article/e2fb804e96e1462596dca5543cf6fb60
Autor:
Michael Berszin, Ioannis Michaelides, Julia Siemert, Louisa Röhl, Jana Wellhausen, Theresa Wald, Christopher Bohr, Julian Künzel, Tanja Gradistanac, Andreas Dietz, Veit Zebralla, Markus Pirlich, Susanne Wiegand, Gunnar Wichmann
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundPembrolizumab and cetuximab are antibodies under investigation in head and neck squamous cell carcinoma (HNSCC) either as single agents or combined with cisplatin and other chemotherapeutic drugs, e.g., 5-fluorouracil and/or docetaxel. Howe
Externí odkaz:
https://doaj.org/article/fba7c6a52eb84eb0b50232b2a2c26e9c
Autor:
Markus Pirlich, Andreas Dietz
Publikováno v:
Wiener klinisches Magazin. 26:100-107
Autor:
Katharina Heuermann, Richard Bieck, Andreas Dietz, Miloš Fischer, Mathias Hofer, Thomas Neumuth, Markus Pirlich
Publikováno v:
Laryngo-Rhino-Otologie. 102:32-39
ZusammenfassungBisherige Navigationssysteme können zwar im Rahmen der funktionellen endoskopischen Nasennebenhöhlenchirurgie (FESS) die Position des „getrackten“ Operationsinstruments in radiologische Schnitt-Bilddaten bestimmen, geben aber kei
Autor:
Markus Pirlich, Andreas Dietz
Publikováno v:
Die Onkologie. 29:51-57
Autor:
Andreas Dietz, Bernd Lethaus, Markus Pirlich, Matthäus Stöhr, Veit Zebralla, Gunnar Wichmann, Rüdiger Zimmerer, Susanne Wiegand
Publikováno v:
Laryngo-Rhino-Otologie. 101:820-831